Bank, W. (2023). https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=IR.

Afshari, S., Daroudi, R., Goudarzi, R., Mahboub-Ahari, A., Yaseri, M., Sari, A. A., Ameri, H., Bahariniya, S., Oliaei-Manesh, A., & Kalavani, K. (2023). A national survey of Iranian general population to estimate a value set for the EQ-5D-5L. Quality of Life Research, 32, 2079–2087.

Article  PubMed  Google Scholar 

Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value in Health., 12, S5–S9.

Article  PubMed  Google Scholar 

Kennedy-Martin, M., Slaap, B., Herdman, M., van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., & Boye, K. S. (2020). Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics, 21, 1245–1257.

Article  PubMed  PubMed Central  Google Scholar 

Devlin, N., Parkin, D., & Janssen, B. (2020). Methods for analysing and reporting EQ-5D data. Springer Nature.

Book  Google Scholar 

Goudarzi, R., Sari, A. A., Zeraati, H., Rashidian, A., Mohammad, K., & Amini, S. (2019). Valuation of quality weights for EuroQol 5-dimensional health states with the time trade-off method in the capital of Iran. Value in Health Regional Issues, 18, 170–175.

Article  PubMed  Google Scholar 

Ameri, H., Safari, H., & Poder, T. (2021). Exploring the consistency of the SF-6Dv2 in a breast cancer population. Expert Review of Pharmacoeconomics & Outcomes Research, 21(5), 1017–1024.

Article  Google Scholar 

Nahvijou, A., Safari, H., & Ameri, H. (2020). Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Services and Outcomes Research Methodology, 20, 183–194.

Article  Google Scholar 

Nahvijou, A., Safari, H., & Ameri, H. (2021). Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population. Breast Cancer, 28, 937–943.

Article  PubMed  Google Scholar 

Nahvijou, A., Safari, H., Yousefi, M., Rajabi, M., Arab-Zozani, M., & Ameri, H. (2021). Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer, 28, 130–136.

Article  PubMed  Google Scholar 

Yousefi, M., Nahvijou, A., Sari, A. A., & Ameri, H. (2021). Mapping QLQ-C30 onto EQ-5D-5L and SF-6D-V2 in patients with colorectal and breast cancer from a developing country. Value in Health Regional Issues, 24, 57–66.

Article  PubMed  Google Scholar 

Xie, S., Wang, D., Wu, J., Liu, C., & Jiang, W. (2022). Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey. Health and Quality of Life Outcomes, 20(1), 1–13.

Article  Google Scholar 

Xie, S., Wu, J., & Chen, G. (2023). Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population. The European Journal of Health Economics, 25, 7–19.

Article  PubMed  Google Scholar 

Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of health economics., 21(2), 271–292.

Article  PubMed  Google Scholar 

Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42, 851–859.

Article  PubMed  Google Scholar 

Brazier, J. E., Mulhern, B. J., Bjorner, J. B., Gandek, B., Rowen, D., Alonso, J., Vilagut, G., & Ware, J. E. (2020). Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Medical Care, 58(6), 557–565.

Article  PubMed  Google Scholar 

Wang, L., & Poder, T. G. (2023). A systematic review of SF-6D health state valuation studies. Journal of Medical Economics, 26(1), 584–593.

Article  PubMed  Google Scholar 

Whitehurst, D. G., Brazier, J. E., Viney, R., & Mulhern, B. J. (2020). The SF-6Dv2: How does the new classification system impact the distribution of responses compared with the original SF-6D? PharmacoEconomics, 38(12), 1283–1288.

Article  PubMed  Google Scholar 

Mulhern, B. J., Bansback, N., Norman, R., & Brazier, J. (2020). Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Medical Care, 58(6), 566–573.

Article  PubMed  Google Scholar 

Mulhern, B., Norman, R., & Brazier, J. (2021). Valuing SF-6Dv2 in Australia using an international protocol. PharmacoEconomics, 39, 1151–1162.

Article  PubMed  Google Scholar 

Poder. T.G., Kouakou, C.R.C., He, J. (2023). Estimatingthe monetary value of a quality-adjusted life-year in Quebec. The European Journal of Health Economics.

Wu, J., Xie, S., He, X., Chen, G., Bai, G., Feng, D., Hu, M., Jiang, J., Wang, X., & Wu, H. (2021). Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension. PharmacoEconomics, 39, 521–535.

Article  PubMed  PubMed Central  Google Scholar 

Kharroubi, S. A. (2018). Valuation of preference-based measures: Can existing preference data be used to generate better estimates? Health and Quality of Life Outcomes, 16, 1–13.

Article  Google Scholar 

Dufresne, É., Poder, T. G., Samaan, K., Lacombe-Barrios, J., Paradis, L., Des Roches, A., & Bégin, P. (2021). SF-6Dv2 preference value set for health utility in food allergy. Allergy, 76(1), 326–338.

Article  PubMed  Google Scholar 

Oppe, M., & van Hout, B. (2021). 2017 The “power” of eliciting EQ-5D-5L values: The experimental design of the EQ-VT. EuroQol Group.

Google Scholar 

Plan, V. P. (2018). Budget Organization Selected Findings of the 2016 National Population and Housing Census. Statistical Centre of Iran.

Google Scholar 

Montazeri, A., Goshtasebi, A., Vahdaninia, M., & Gandek, B. (2005). The short form health survey (SF-36): Translation and validation study of the Iranian version. Quality of Life Research, 14, 875–882.

Article  PubMed  Google Scholar 

Bansback, N., Brazier, J., Tsuchiya, A., Anis, A. (2010). Using a discrete choice experiment to estimate societal health state utility values. HEDS Discussion Paper.

Pacifico, D., & Yoo, H. I. (2013). lclogit: A Stata command for fitting latent-class conditional logit models via the expectation-maximization algorithm. The Stata Journal, 13(3), 625–639.

Article  Google Scholar 

Safari, H., Poder, T. G., Afshari, S., Nahvijou, A., Arab-Zozani, M., Moradi, N., & Ameri, H. (2022). Determination of a cost-effectiveness threshold for cancer interventions in Iran. Frontiers in Oncology, 12, 1039589.

Article  PubMed  PubMed Central  Google Scholar 

Touré, M., Pavic, M., & Poder, T. G. (2023). Second version of the short form 6-dimension value set elicited from patients with breast and colorectal cancer: A hybrid approach. Medical Care, 61, 536–545.

Article  PubMed  Google Scholar